Europe’s drug regulator said on Monday it was evaluating data on a booster dose for Pfizer/BioNtech’s COVID-19 vaccine, which will be administered to people 16 years and older six months after the second dose.
The drug manufacturers filed an application with European Medicines Agency (EMA) said it would conduct a quick evaluation of the data, with an expected outcome “within the next few weeks”.
On Friday, US-based moderna said that it had asked the EMA for conditional approval of a booster shot of its coronavirus vaccine at the 50 microgram dose. Moderna and Pfizer’s two-dose shots are both based on new mRNA technology.
The EMA also said on Monday that it was assessing data on the use of an additional dose of mRNA vaccines in people with weakened immune systems. The result of that review will be given in due course, it said.
last week, european center for disease prevention and control He said that there is no urgent need for booster doses of COVID-19 vaccines for complete immunization.
However, as America’s top infectious disease expert Anthony Fauci said on Sunday that the United States is gearing up to roll out booster doses, officials are likely to soon see regulatory moves from Pfizer to booster shots.
The drug manufacturers filed an application with European Medicines Agency (EMA) said it would conduct a quick evaluation of the data, with an expected outcome “within the next few weeks”.
On Friday, US-based moderna said that it had asked the EMA for conditional approval of a booster shot of its coronavirus vaccine at the 50 microgram dose. Moderna and Pfizer’s two-dose shots are both based on new mRNA technology.
The EMA also said on Monday that it was assessing data on the use of an additional dose of mRNA vaccines in people with weakened immune systems. The result of that review will be given in due course, it said.
last week, european center for disease prevention and control He said that there is no urgent need for booster doses of COVID-19 vaccines for complete immunization.
However, as America’s top infectious disease expert Anthony Fauci said on Sunday that the United States is gearing up to roll out booster doses, officials are likely to soon see regulatory moves from Pfizer to booster shots.
.